These success, together with a preceding report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 help the strategy of concentrating on ACKR3 as a novel method to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-connected Problems.At that point, Microsoft Advertisin